Amneal Pharmaceuticals (FRA:2DT) Cash Flow for Lease Financing : €0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Amneal Pharmaceuticals Cash Flow for Lease Financing?

Amneal Pharmaceuticals's Cash Flow for Lease Financing for the three months ended in Mar. 2025 was €0 Mil. Amneal Pharmaceuticals's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 was €0 Mil.

Compared with last quarter (€0 Mil in Dec. 2024 ), Amneal Pharmaceuticals's Cash Flow for Lease Financing remained the same in Mar. 2025 (€0 Mil).

Amneal Pharmaceuticals Cash Flow for Lease Financing Historical Data

The historical data trend for Amneal Pharmaceuticals's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amneal Pharmaceuticals Cash Flow for Lease Financing Chart

Amneal Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash Flow for Lease Financing

Get a 7-Day Free Trial

Amneal Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Cash Flow for Lease Financing	Get a 7-Day Free Trial															-	-	-	-	-

Amneal Pharmaceuticals Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.

Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

Amneal Pharmaceuticals Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Amneal Pharmaceuticals's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Amneal Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amneal Pharmaceuticals Inc (FRA:2DT) » Definitions » Cash Flow for Lease Financing

Comparable Companies

Traded in Other Exchanges

AMRX:USA

Address

400 Crossing Boulevard, 3rd Floor, Bridgewater, NJ, USA, 08807

Website

https://www.amneal.com

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Amneal Pharmaceuticals Headlines

No Headlines